focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: IP Group, Millennium & Copthorne Lead FTSE 350 Risers

Fri, 21st Feb 2014 11:57

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.

-------

FTSE 100 - WINNERS

Royal Bank of Scotland Group, up 2.4%. The bank is preparing a dramatic retrenchment that would see it become a much smaller UK retail and commercial bank, a move that is expected to see staff numbers slashed by at least 30,000 in the coming years, the Financial Times has reported, citing people familiar with the bank's plans. In the wake of the news, Shore Capital has reiterated its Buy recommendation, saying that the move is likely to result in a, "smaller but more efficient, higher return and less risky bank."

GlaxoSmithKline, up 0.6%. The pharmaceuticals company said that Incruse, a treatment for chronic obstructive pulmonary disease, had been recommended for marketing authorisation by the European Medicines Agency's committee for Medical Products for Human Use, a key step in getting approval for the drug. Anoro, a combination treatment for the disease, is also undergoing regulatory review.

Royal Dutch Shell, up 0.6%. The European oil giant said it has reached a binding agreement to sell its Australia downstream businesses, excluding Aviation, to Dutch-owned oil trader Vitol for a total transaction value of around AUD2.9 billion or USD2.6 billion. The deal is expected to close in 2014.

-------

FTSE 100 - LOSERS

Smiths Group, down 2.1%. UBS has downgraded the company to Sell from Neutral, lowering its price target to 1,340.00 pence, from 1,450.00p. UBS analyst Mark Fielding says that the company came out in the "bottom quartile" in its sector quality analysis looking at historical performance and that, a three year earnings per share compound annual growth rate of approximately 5% is at the low-end of the group.

-------

FTSE 250 - WINNERS

IP Group, up 9.3%. The firm said that its portfolio company, Xeros Ltd, intends to float on AIM to raise funds to bring its patented polymer bead cleaning system to the laundry market. The funds raised in the AIM initial public offering are expected to support Xeros in rolling out in the commercial laundry market, and to fund the research and development process through to commercialisation in other identified applications, not least in domestic laundry. IP Group has an undiluted beneficial stake of 14.6% in Xeros.

Millennium & Copthorne Hotels, up 4.7%. The firm reported a pretax profit of GBP167.7 million for the fourth quarter of 2013, up from only GBP54.2 million a year earlier, and a pretax profit of GBP263.6 million for the year as a whole, compared with a profit of GBP171.3 million in 2012. Group revenue increased to the record level of GBP1.04 billion in 2013, due to a GBP273.7 million revenue boost from the Glyndebourne development in Singapore. It has sold 147 out of 150 apartments built on the site of the former Copthorne Orchid Hotel in Singapore.

Informa, up 1.5%. The business media and events company pledged to deliver further growth in adjusted earnings per share in 2014, as it reported improved revenue and pretax profit for 2013 in the first set of results under new Chief Executive Stephen Carter. Its pretax profit in 2013 was GBP115.7 billion, up from GBP70.4 billion in 2012, with revenues increasing to GBP1.13 billion, from GBP1.11 billion. It maintained its final dividend at 12.50 pence, bringing its total dividend to 18.90 pence, up from 18.50 pence in the previous year. The new CEO said a key objective for Informa in 2014 will be managing the transition in leadership as smoothly and effectively as possible. He set out two major challenges for Informa: addressing the shift in technology happening in Informa's market, and returning the company's Business Intelligence division to growth.

-------

FTSE 250 - LOSERS

Vesuvius, down 2.8%. UBS has initiated the company with a Sell rating and price target of 440.00p. UBS says that while the company is not expensive on headline valuations, in the context of its engineering sector coverage it sees a, "significant sector valuation discount as justified."

-------

AIM - WINNERS

Churchill Mining, up 35%. The thermal coal producer said it expects to receive a ruling on its international arbitration claim against the Republic of Indonesia on February 24. The company added that a temporary suspension in trading of the Company's shares on AIM will take effect on February 24 and the shares will restart trading following a notification of the ruling.

Planet Payment, up 8.9%. The company's shares have jumped after it said it had applied for 21,892 new shares to be admitted to trading on AIM in accordance with the exercise of warrants. The shares are to be issued to the holder of a warrant issued in 2009, following the exercise of warrants at an exercise price of 45 US cents per share.

Pentagon Protection, up 7.9%. The firm said that it swung to a pretax profit as revenue more than doubled in its last financial year. It reported a pretax profit of GBP391,415 for the year to September 30, 2013, compared with a pretax loss of GBP523,474 a year earlier, as it saw revenue more than double to GBP5.4 million, from GBP2.0 million.

-------

AIM - LOSERS

The Real Good Food Company, off 28%. The baker and sugar producer has said it is in a pricing dispute with the sugar subsidiary of Associated British Foods. The company said it is unlikely that the pricing dispute with British Sugar will be resolved in the near future, and it will hit earnings both this year and next year. British Sugar is a major supplier to The Real Good Food Company's Napier Brown non-refining sugar distribution business.

Airea, down 27%. The group said that pretax profit and revenues fell during the half-year, as it continues restructuring plans amid ongoing "hostile market conditions." Revenue for the six months to December 31, 2013, fell to GBP11.6 million from GBP13.5 million a year earlier, and operating profit followed suit, coming in at GPB222,000, down from GBP359,000 in 2012. Pretax profit declined to GBP24,000 from GBP270,000 last year and from GBP533,000 in the previous six month period.

-------

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.